Rifamycin S CAS 13553-79-2 Puritas >97.5% (HPLC) Factory
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Rifamycin S (CAS: 13553-79-2) with high quality. We can provide COA, worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com
Nomen chemicum | Rifamycin S |
Synonyma | 1,4-Dideoxy-1,4-Dihydro-1,4-Dioxorifamycin;Rifaximin EP Impuritas E |
CAS Number | 13553-79-2 |
CATTUS Number | RF-PI2058 |
Stock Status | In Stock, Productio Capacitas 500MT/Annus |
Formulae hypotheticae | C37H45NO12 |
M. Pondus | 695.76 |
Sensibilitas | Calor Sensitiva |
Imprimis rotationis [α]20/D | +451.0°~+500.0° (C=0.1 in MeOH) |
Liquescens punctum | 201℃ |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Flavo vel Orange Yellow Crystalline pulveris |
Damnum in Siccatio | ≤3.00% (4h 100℃) |
Residere in Ignition | ≤0.50% |
Substantiae cognatae | |
Rifamycin-O | ≤0.50% |
Rifamycin-B | ≤0.50% |
unus cacumine | ≤1.00% |
Totalis immunditias | ≤2.50% |
Puritas / Analysis Methodus | >97.5% (HPLC) |
Infrared Imaginis | Conformat ut Structure |
Proton NMR Spectrum | Conformat ut Structure |
Test Standard | Enterprise Standard |
Fasciae vita | XXIV Menses ex Manufacture Date si Repono Proprie |
Consuetudinem | Clavis media ad Synthesim Medicinae Rifamycin |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
Rifamycin S (CAS: 13553-79-2) clavis media est ad medicamenta synthesis rifamycin.Rifamycin S est antibioticum semi-syntheticum.Rifamycin S quinone est et agnet antibioticus contra bacteria Gram-positiva (inclusa MRSA).Rifamycin S formae oxidizatae convertitur systematis oxidationis-reductionis duo electrons involventium.Rifamycin S species oxygenii reactiva (ROS) generat et peroxidationem lipidorum microsomalem vetat.Rifamycin S ad tuberculosis et lepra adhiberi potest.Rifamycini globi sunt antibioticorum chemicorum relatarum quae fermento ab culturarum Streptomycesmediterranei obtentae sunt.Ad genus pertinent antibioticorum, qui theansamycinum vocant, continentes anulum macrocyclicum trans duos positiones nuclei aromatici non adiacentes.Rifamycini et multae derivationes semisyntheticae habent latum spectrum actionis antimicrobialis.Praecipue sunt activae contra bacteria Gram-positiva et M. tuberculosis.Tamen etiam activae sunt contra gram-negativam bacteria et multa virus.Rifampin, derivatio asemisynthetica Rifamycin B, quasi agens anantitubercularis in Civitatibus Foederatis Americae anni 1971 dimissa est. Secunda derivatio secunda, rifabutin anno 1992 probata est, ante tractationem contagionum atypicae mycobacteriales.